Cervical-cancer screening - New guidelines and the balance between benefits and harms

New England Journal of Medicine

Volumn 361, Issue 26, 2009, Pages 2503-2505

  Sawaya, George F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CANCER STAGING; COLPOSCOPY; DIAGNOSTIC PROCEDURE; HEALTH SERVICE; HUMAN; MORBIDITY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 73549102660     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0911380     Document Type: Article

References (5)

1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin number 109, December 2009: cervical cytology screening. Obstet Gynecol 2009;114:1409-20.
2. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med 2007;147:871-5.
3. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin number 99, December 2008: management of abnormal cervical cytology and histology. Obstet Gynecol 2008;112:1419-44.
4. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:489-98.
5. Sawaya GF, McConnell KJ, Kulasingam SL, et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 2003;349:1501-9.